Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Ronald W. Barrett,PhDCEO, Director229,2030.37%2015-01-13
William J. Dower,PhDVP, Discovery Biology201,6290.32%2006-03-15
William G. HarrisSVP, Finance and CFO147,1110.23%2015-01-13
Vincent J. AngottiN/A104,8480.17%2015-01-13
Ms. Gianna M. BoskoSVP, CLO and Secretary92,8370.15%2015-01-13
Dr. Ernest Mario,PhDDirector83,7500.13%2014-05-23
Dr. Pierre V. Tran,M.D.N/A83,3310.13%2005-06-01
Dr. David R. Savello,PhDN/A78,5060.13%2014-01-13
Dr. Paul Goddard,PhDN/A50,831less than 0.1%2005-06-07
Dr. Kenneth C. Cundy,PhDSVP, Preclinical Development43,851less than 0.1%2012-03-12

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
WIERENGA WENDALLDirector2015-05-11Buy5,00028,998$5.6328.29.5928,998 (Direct)
RIEFLIN WILLIAM JLDirector2014-12-10Sell11,010302,845$8.4993.5-27.3321,660 (Direct)
281,117 (By Trust)
68 (Through Fund)
Barrett Ronald WCEO
(Click for the stocks that their CEOs have bought)
2014-12-08Sell7,015334,682$8.3658.6-26.2166,443 (Direct)
168,239 (By Trust)
BATES GREGORY TSVP, Regulatory Affairs & QA2014-12-08Sell14,16620,747$8.35118.3-26.1120,747 (Direct)
Bosko Gianna MSVP, CLO and Secretary2014-12-05Sell60,00077,072$8.45507-26.9877,072 (Direct)
BATES GREGORY TSVP, Regulatory Affairs & QA2014-09-09Sell5,61220,747$5.2629.517.320,747 (Direct)
Freund John GordonDirector2014-06-03Buy12,500498,395$3.9349.1578,899 (Direct)
27 (Beneficial Ownership)
489,469 (Through Fund)
FENTON DENNIS MDirector2014-05-27Buy3,00014,300$4.0212.153.4813,000 (Direct)
1,300 (By Trust)
FRIEDMAN CATHYDirector2014-05-27Buy2,60014,900$3.9210.257.412,300 (Direct)
2,600 (By Trust)
WIERENGA WENDALLDirector2014-05-27Buy10,00023,998$3.9939.954.6423,998 (Direct)
MARIO ERNESTDirector2014-05-23Buy30,00083,750$3.73111.965.4283,750 (Direct)
Freund John GordonDirector2014-05-23Buy15,000498,395$3.735665.428,899 (Direct)
27 (Beneficial Ownership)
489,469 (Through Fund)
Barrett Ronald WCEO2014-05-23Buy2,600342,978$3.759.864.53173,458 (Direct)
168,239 (By Trust)
1,281 (By Children)
BERNS PAUL LDirector2014-05-15Sell2,5005,000$3.669.268.585,000 (Direct)
BERNS PAUL LDirector2014-04-24Sell2,5002,500$4.310.843.492,500 (Direct)
BATES GREGORY TSVP, Regulatory Affairs & QA2013-06-14Sell7,50016,540$5.3540.115.3316,540 (Direct)
MARIO ERNESTDirector2013-05-22Buy20,00030,000$5.49109.812.3930,000 (Direct)
MARIO ERNESTDirector2012-08-09Buy10,00010,000$8.585-27.4110,000 (Direct)
RIEFLIN WILLIAM JLDirector2011-12-16Buy10,000281,117$3.8638.659.84
281,117 (By Trust)
RIEFLIN WILLIAM JLDirector2011-11-21Buy10,000271,117$4.4444.438.96
271,117 (By Trust)

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK